Tempus AI Stock Surges Amid Options Frenzy and Nancy Pelosi's Investment

Market Whales and Their Recent Bets on TEM Options - Tempus AI (NASDAQ:TEM)

Financial giants have made a conspicuous bearish move on Tempus AI. Our analysis of options history for Tempus AI TEM revealed 49 unusual trades. Delving into the details, we found 36% of traders were bullish, while 42% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $52,770, and 47 were calls, valued at $3,193,431. Projected Price Targets After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $100.0 for Tempus AI, spanning the last three months. Analyzing Volume & Open Interest Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Tempus AI's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Tempus AI's significant trades, within a strike price range of $20.0 to $100.0, over the past month. Tempus AI Call and Put Volume: 30-Day Overview Biggest Options Spotted: Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume TEM CALL SWEEP NEUTRAL 04/17/25 $5.7 $5.1 $5.1 $80.00 $472.0K 6.9K 0 TEM CALL SWEEP NEUTRAL 04/17/25 $3.5 $3.3 $3.5 $90.00 $203.4K 11.0K 1.3K TEM CALL SWEEP BULLISH 01/16/26 $27.0 $25.9 $26.78 $50.00 $133.6K 2.8K 211 TEM CALL TRADE BEARISH 01/16/26 $27.0 $26.3 $26.5 $50.00 $132.5K 2.8K 314 TEM CALL TRADE NEUTRAL 01/16/26 $26.9 $26.1 $26.43 $50.00 $132.1K 2.8K 96 About Tempus AI Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. After a thorough review of the options trading surrounding Tempus AI, we move to examine the company in more detail. This includes an assessment of its current market status and performance. Tempus AI's Current Market Status With a volume of 14,494,605, the price of TEM is up 2.62% at $66.69. RSI indicators hint that the underlying stock may be overbought. Next earnings are expected to be released in 14 days. What Analysts Are Saying About Tempus AI Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $60.666666666666664. Unusual Options Activity Detected: Smart Money on the Move Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $56. * An analyst from Loop Capital persists with their Buy rating on Tempus AI, maintaining a target price of $52. * An analyst from TD Cowen downgraded its action to Buy with a price target of $74. Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely. If you want to stay updated on the latest options trades for Tempus AI, Benzinga Pro gives you real-time options trades alerts. TEMTempus AI Inc$67.303.55%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs

Tempus AI's Options Frenzy: What You Need to Know - Tempus AI (NASDAQ:TEM)

Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 61% with bearish. From the overall spotted trades, 2 are puts, for a total amount of $57,378 and 19, calls, for a total amount of $1,237,552. Predicted Price Range Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $85.0 for Tempus AI during the past quarter. Insights into Volume & Open Interest Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Tempus AI's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Tempus AI's substantial trades, within a strike price spectrum from $20.0 to $85.0 over the preceding 30 days. Tempus AI 30-Day Option Volume & Interest Snapshot Noteworthy Options Activity: Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume TEM CALL SWEEP BULLISH 03/21/25 $9.4 $9.1 $9.1 $55.00 $220.2K 1.6K 797 TEM CALL SWEEP BEARISH 04/17/25 $7.8 $7.4 $7.5 $60.00 $131.7K 1.1K 208 TEM CALL TRADE BULLISH 01/15/27 $26.1 $23.7 $25.3 $50.00 $126.5K 317 50 TEM CALL SWEEP BEARISH 03/21/25 $8.5 $8.2 $8.29 $55.00 $82.5K 1.6K 348 TEM CALL TRADE BEARISH 03/21/25 $7.9 $6.5 $7.0 $55.00 $70.0K 1.6K 100 About Tempus AI Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. Where Is Tempus AI Standing Right Now? Trading volume stands at 11,320,306, with TEM's price up by 11.31%, positioned at $56.51. RSI indicators show the stock to be may be overbought. Earnings announcement expected in 18 days. What The Experts Say On Tempus AI In the last month, 2 experts released ratings on this stock with an average target price of $54.0. Turn $1000 into $1270 in just 20 days? 20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Maintaining their stance, an analyst from Loop Capital continues to hold a Buy rating for Tempus AI, targeting a price of $52. * An analyst from Needham downgraded its action to Buy with a price target of $56. Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tempus AI with Benzinga Pro for real-time alerts. TEMTempus AI Inc$56.9612.2%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs

8 Analysts Have This To Say About Tempus AI - Tempus AI (NASDAQ:TEM)

In the latest quarter, 8 analysts provided ratings for Tempus AI TEM, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 1 3 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 1 1 1 0 0 3M Ago 0 0 2 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $63.12, with a high estimate of $74.00 and a low estimate of $52.00. Witnessing a positive shift, the current average has risen by 26.24% from the previous average price target of $50.00. Exploring Analyst Ratings: An In-Depth Overview A clear picture of Tempus AI's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Dan Brennan TD Cowen Announces Buy $74.00 - Mark Schappel Loop Capital Lowers Buy $52.00 $57.00 Ryan MacDonald Needham Maintains Buy $56.00 $56.00 Michael Ryskin B of A Securities Raises Neutral $54.00 $52.00 Doug Schenkel Wolfe Research Announces Outperform $60.00 - Subbu Nambi Guggenheim Announces Buy $74.00 - David Westenberg Piper Sandler Raises Neutral $70.00 $40.00 Daniel Arias Stifel Raises Hold $65.00 $45.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Tempus AI. This information provides a snapshot of how analysts perceive the current state of the company. Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Tempus AI compared to the broader market. Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Tempus AI's stock. This comparison reveals trends in analysts' expectations over time. Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Tempus AI's market standing. Stay informed and make well-considered decisions with our Ratings Table. Stay up to date on Tempus AI analyst ratings. About Tempus AI Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. Understanding the Numbers: Tempus AI's Finances Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers. Revenue Growth: Tempus AI's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 32.98%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector. Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -41.92%, the company may need to address challenges in effective cost control. Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -99.8%, the company may need to address challenges in generating satisfactory returns for shareholders. Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -8.26%, the company may need to address challenges in generating satisfactory returns from its assets. Debt Management: With a high debt-to-equity ratio of 8.78, Tempus AI faces challenges in effectively managing its debt levels, indicating potential financial strain. What Are Analyst Ratings? Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors. If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro. Breaking: Wall Street's Next Big Mover Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details. This article was generated by Benzinga's automated content engine and reviewed by an editor. TEMTempus AI Inc$63.803.15%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs

Tempus AI Stock Soars On Nancy Pelosi's Call Options -- But Should Investors Follow? - Tempus AI (NASDAQ:TEM)

However, the lack of overt directional bias makes TEM stock an advanced volatility hedge. Despite the fractious nature of U.S. politics, the American public has reached a consensus: former House Speaker Nancy Pelosi is the undisputed investing champion. As a result, her acquisition of Tempus AI Inc TEM call options has generated considerable buzz, leading to significant activity in the stock. Still, only the most advanced traders should take the bait. At first glance, Tempus AI might seem like an alluring investment. A health technology firm, Tempus -- as its name suggests -- utilizes artificial intelligence to create precision medicine solutions. In addition, the company is involved in diagnostics-based solutions for oncology, cardiology, radiology and depression. Analysts at SkyQuest note that the precision medicine market could reach a valuation of $75.3 billion by 2031, implying a compound annual growth rate of 11.4% from 2024. While the underlying relevance and potential of Tempus AI has certainly boosted TEM stock, Pelosi has generated substantial buzz. Much of the enthusiasm centers on her uncanny ability to read the market. At the end of December, Pelosi sold 10,000 shares of Nvidia Corp. NVDA worth between $1 million and $5 million. Not long after, the Chinese AI model DeepSeek sent the tech sector tumbling. Sure enough, NVDA represented the worst-hit name among the so-called Magnificent 7 stocks. Not surprisingly, retail traders are making the logical connection that if Pelosi knows when to sell a security, she offers an insightful barometer regarding when to buy. Since selling a hot hand takes extraordinary discipline and conviction, it's not at all an unreasonable conclusion. Nevertheless, TEM stock warrants sober analysis before entry. Tempus Prices in the Expected Filibuster According to the website of the U.S. Senate, a filibuster is "a loosely defined term for action designed to prolong debate and delay or prevent a vote on a bill, resolution, amendment, or other debatable question." Thus, Tempus represents Wall Street's filibuster in that it consumes considerable trading activity but without clear direction. For one thing, prospective investors must consider the financial framework. Without earnings and also without a clear path to near-term profitability, Tempus stock is highly speculative. On the top line, analysts are projecting revenue to land somewhere north of $693 million. That puts the projected annual sales growth to approximately 30%. While the growth sounds impressive, Tempus stock also trades at a sales multiple of nearly 14-times trailing-12-month (TTM) revenue. Generally speaking, the individual segments within the broader healthcare ecosystem feature a revenue multiple no greater than five times. So, from that perspective, Tempus is significantly overvalued. Sure enough, the hot premium explains the negative bias of Tempus stock. To be 100% clear, there is very limited data available for Tempus, which had its initial public offering last June. Nevertheless, from the data gathered, the negative bias is apparent. On a week-to-week basis, the stochastic framework (devoid of any other context aside from the temporal) shows that a position entered at the beginning of the period only has a 45.45% chance of rising by the end of it. Over a four-week basis, the odds improve slightly (but are still poor) at 46.67%. From the time-of-writing trend, Tempus is trending for a 20%-plus return for this week. So far, whenever Tempus posted a double-digit-percentage gain in a one-week period, only one-third of the time did it rise by the end of the fourth subsequent week. Neither Bulls Nor Bears Have an Edge Based on the dynamic condition of Tempus stock posting a one-week double-digit gain, the best odds that traders can hope for is in the next week following the extreme-greed event. Even then, the odds are 50/50, which really means that neither the bulls nor the bears have an edge. And while subsequent weeks technically favor the bears, the sampling size is extremely small. Therefore, Tempus is an advanced volatility hedge. From the limited statistical evidence available, the median four-week return following an extreme-greed event under the positive scenario stands at a hearty 35.28%. On the other hand, the median loss under the same conditions sits at 11.17%. Assuming that Friday's session closes at $60, Tempus stock could potentially either rise to $81.17 or fall to $52.34 by the options chain expiring Feb. 28. The problem is that market makers appear to be anticipating high volatility for that expiration date. Therefore, the condors available are unfavorable. Instead, it may be more prudent to consider the options chain expiring one week earlier on Feb. 21. Again, from the limited data available, it's possible that Tempus stock could rise to $80.63 or fall to $52.36 for that cycle. The most aggressive (but arguably still rational) idea is the 55P | 60P || 75C | 80C long iron condor for the Feb. 21 expiration date. This transaction combines the 55/60 bear put spread and the 75/80 bull call spread, allowing traders to win by an extreme movement in either direction. Now Read: White House Confirms Tariffs On Key US Trade Partners This Weekend Image: Shutterstock TEMTempus AI Inc$58.171.72%WatchlistOverviewNVDANVIDIA Corp$122.27-1.91%Market News and Data brought to you by Benzinga APIs